In Section A, contributors will receive diverse doses and schedules of oral ABBV-744 pill to determine Safe and sound dosing program. Further members will be enrolled with the discovered monotherapy dosign program. In Phase B, participants will obtain oral ruxolitinib and ABBV-744 might be given as "incorporate-on" therapy. In Section https://zanderokyit.blog2freedom.com/31911408/the-basic-principles-of-abbv-744-in-acute-myeloid-leukemia-aml